ArticleJournal of muscle research and cell motility2025
Smooth muscle cells from skin perforator vessels as a new tool for vascular research.
Article in Journal of muscle research and cell motility, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Smooth muscle contractile cytoskeleton in health and disease.Journal of muscle research and cell motility · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vascular smooth muscle cells (SMC) comprise the medial layer of blood vessels and are responsible for maintaining vascular tone. Ordinarily quiescent and contractile, SMC can dedifferentiate into different phenotypes following injury or in disease states such as atherosclerosis and are thus valuable research tools for examining these conditions. The isolation of commonly used SMC types, such as those from the aorta or saphenous vein (SV), require clinical links or commercial supply and are rarely pathology-free. The skin is highly vascularised with perforator (Perf) vessels that protrude through the skin layers to feed the tissue. Whilst these vessels can be sourced from clinical procedures (e.g. reconstructive surgery), they are also available from elective cosmetic procedures such as abdominoplasty which could provide blood vessels unaffected by an underlying pathology. This paper describes the isolation of Perf-SMC for the first time, using a cost-effective explant technique. Explanted cells were confirmed as SMC by co-staining for alpha smooth muscle actin and smooth muscle myosin heavy chain. Phenotypic characteristics of Perf-SMC (cell morphology, proliferation, and multinucleation) were comparable to those from commonly used SMC from alternative vascular sources (SV-SMC and umbilical artery SMC). Furthermore, Perf-SMC were stable in culture up until at least passage 9 with no alteration in morphological characteristics or evidence of replication-induced phenotypic change. In summary, this paper describes an effective, efficient and low-cost method for isolating SMC from skin perforator vessels that may be a useful tool for the future examination of SMC behaviour from both pathological and healthy skin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.